srch

The Acta Pharmaceutica Sinica B Impact Factor IF measures the average number of citations received in a particular year (2020) by papers published in the Acta Pharmaceutica Sinica B during the two preceding years (2018-2019).

Jan 08, 2022 · The Acta Pharmaceutica Sinica B Impact Factor IF measures the average number of citations received in a particular year (2021) by papers published in the Acta Pharmaceutica Sinica B during the two preceding years (2019-2020).

03.01.2022 · The 2021-2022 Journal Impact IF of Acta Pharmaceutica is 2.23, which is just updated in 2022. Acta Pharmaceutica Journal Impact IF Highest IF 2.23 Key Factor Analysis Lowest IF 0.912 Key Factor Analysis Total Growth Rate 144.5% Key Factor Analysis Annual Growth Rate 14.4% Key Factor Analysis Acta Pharmaceutica Journal Key Metrics Acta …

Note that 2020 Impact Factor are reported in 2021; they cannot be calculated until all of the 2020 publications have been processed by the indexing agency. New ...

Nov 16, 2021 · The impact score (IS) 2020 of Acta Pharmaceutica Sinica B is 10.62, which is computed in 2021 as per its definition.Acta Pharmaceutica Sinica B IS is increased by a factor of 3.7 and approximate percentage change is 53.47% when compared to preceding year 2019, which shows a rising trend.

Read the latest articles of Acta Pharmaceutica Sinica B at ... 11.614Impact Factor ... In Press, Journal Pre-proof, Available online 31 December 2021 ...

Acta Pharmaceutica Sinica B (APSB) is delighted to announce that the Impact Factor (IF) of the journal is now 11.413 in 2020 according to ...

16.11.2021 · The impact score (IS) 2020 of Acta Pharmaceutica Sinica B is 10.62, which is computed in 2021 as per its definition. Acta Pharmaceutica Sinica B IS is increased by a factor of 3.7 and approximate percentage change is 53.47% when compared to preceding year 2019, which shows a rising trend.

Jun 13, 2018 · 2020 High Impact Paper Award. September 28, 2021. APSB 2020 Impact Factor & quartile information problem correction announced for October 2021. July 19, 2021. 2017 Hot Papers in Acta Pharmaceutica Sinica B. June 14, 2018. View all news

CiteScore. 12.5 ; Impact Factor. 11.614 ; Acceptance Rate. 9% ; Time to First Decision. 2.3 weeks ; Review Time. 3.6 weeks.

16.11.2021 · Acta Pharmaceutica Sinica B (APSB) is a monthly journal, ... Impact Factor 11.614. CiteScore 12.5. View articles Submit your paper. Home. Journals. Acta Pharmaceutica Sinica B. ... APSB is celebrating its 10th anniversary in 2021. Back Cover - …

Jan 03, 2022 · The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Acta Pharmaceutica.

Volume 11, Issue 10 October 2021 About the journal Acta Pharmaceutica Sinica B (APSB) is a monthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural …

Neuroprotective effect of sodium ferulate and signal transduction mechanisms in the aged rat hippocampus · Pages: 1399-1408 · First Published: 14 December 2008.

Acta Pharmaceutica Sinica B (APSB) is delighted to announce that the Impact Factor (IF) of the journal is now 11.413 in 2020 according to the latest Clarivate Journal Citation Reports*. APSB ranks No. 9 (Q1 quartile) of the 275 journals in the Pharmacology and Pharmacy category. The Scopus 2020 CiteScore for APSB is 12.5, ranking No. 1, for the third year, of the 67 journals in …

Today, let's take a look at this SCI journal: Acta Pharmaceutica Sinica B. Judging from the existing records, the 2021 Impact Factor ...

14.07.2021 · Acta Pharmaceutica Sinica B (APSB) is delighted to announce that the Impact Factor (IF) of the journal is now 11.413 in 2020 according to the latest Clarivate Journal Citation Reports*. APSB ranks...

The new Impact Factor of Acta Pharmacologica Sinica (APS) is 6.15 and the Total Cites is 12410 according to the Journal Citation Reports by Clarivate Analytics. The Impact Factor ranking of APS has been promoted to a new record in the Pharmacology & Pharmacy journals (30/275, Q1) and the Multidisciplinary Chemistry journals (45/179, Q2).

The impact factor relates to a specific time period; it is possible to calculate it for any desired period. In addition to the 2-year Impact Factor, the 3-year Impact Factor, 4-year Impact Factor, 5-year Impact Factor, Real-Time Impact Factor can provide further insights and factors into the impact of Acta Pharmaceutica Sinica B.

21.12.2021 · Acta Pharmaceutica Sinica B The 2021-2022 Journal Impact IF of Acta Pharmaceutica Sinica B is 11.413, which is just updated in 2022. Acta Pharmaceutica Sinica B Journal Impact IF Highest IF 11.413 Key Factor Analysis Lowest IF 0.444 Key Factor Analysis Total Growth Rate 375.5% Key Factor Analysis Annual Growth Rate 53.6% Key Factor Analysis

About Acta Pharmacologica Sinica ; 2019, -, 5.064, 162, 9668 ; 2018, -, 4.010, 184, 8687.

13.06.2018 · acta pharmaceutica sinica b (apsb) is a monthly journal, in english, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis …

APS (Acta Pharmacologica Sinica), the top pharmacology research journal based in China, publishes original articles and ... Review Article 06 December 2021 ...

Acta Pharmaceutica Sinica B open access ... The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

摘要 Acta Pharmaceutica Sinica B(APSB)is delighted to announce that the Impact Factor(IF)of the journal is now 11.614 in 2020 according to the latest Clarivate Journal Citation Reports.APSB ranks No.9(Q1 quartile)of the 276 journals in the Pharmacology and Pharmacy category.